SRI-29329,2086809-58-5

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SRI-29329

CAS No. : 2086809-58-5

MCE 国际站：SRI-29329

产品活性：SRI-29329 是特异性的 CLK 抑制剂，对CLK1、CLK2 和 CLK4 的IC₅₀ 值分别为 78 nM、16 nM 和 86 nM。

研究领域：Cell Cycle/DNA Damage

作用靶点：CDK

In Vitro: SRI-29329 (compound 8) shows some modest (~5 fold) selectivity for CLK2 over CLK1 and CLK4 without significant CDK1,4,6 activity.

相关产品：Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Kinase Inhibitor Library  |  Anti-Aging Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Cancer Stem Cells Compound Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Serine/Threonine Kinase Inhibitor Library  |  Palbociclib  |  Abemaciclib  |  Ro-3306  |  Ribociclib  |  Dinaciclib  |  GSK3326595  |  THZ1  |  Flavopiridol  |  SR-4835  |  (R)-Roscovitine  |  THZ531  |  AZD4573  |  SY-5609  |  Kenpaullone  |  Wogonin  |  SNS-032  |  GSK 3 Inhibitor IX  |  Cirtuvivint  |  NVP-2  |  Toyocamycin  |  Fadraciclib  |  Simurosertib  |  AT7519  |  OTS964 hydrochloride  |  JNJ-7706621  |  KB-0742 dihydrochloride  |  BSJ-4-116

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds